#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune hepatitis Malignant melanoma Vascular malformation Metastatic gastric cancer Eosinophilic granulomatosis with polyangiitis Laryngeal squamous cell carcinoma Uveal melanoma Immune-mediated myositis Richter's syndrome Ureteric cancer Pyruvate kinase deficiency anaemia Obesity Follicle centre lymphoma follicular grade I, II – III Liver abscess Glomerulonephritis membranous More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Mucous membrane pemphigoid – Trials in Disease Breast angiosarcoma Alexander disease – Trials in Disease Nodal marginal zone B-cell lymphoma – Trials in Disease Mucopolysaccharidosis Extranodal marginal zone B-cell lymphoma (MALT type) Basal cell naevus syndrome – Life with Disease Friedreich’s ataxia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pabinafusp Alfa Pentosan Polysulfate Sodium Sulfonamides, Urea Derivatives Interferon Beta-1B Goserelin Acetate PRILOCAINE HYDROCHLORIDE Grwd5769 RP3 Dosulepin Hydrochloride Gs-5718-03 Tx200-Tr101 Phenobarbital Cx-037231 SALICYLIC ACID Perampanel Gad20-209-Fsp-A1 Bevacizumab Zirconium Zr-89 Eribulin Mesylate Etoposide Florquinitau (18F) More therapies…

    Learn about Your Condition

    Hyperthyroidism Laryngeal cancer stage I Aplasia pure red cell Psychotic behaviour Multiple system atrophy Synovial sarcoma Liposarcoma metastatic Chronic kidney disease Chronic myeloid leukaemia Primary hyperoxaluria Hypertriglyceridaemia Marfan's syndrome Oral herpes Paraganglion neoplasm Juvenile idiopathic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness of Infliximab, Tofacitinib, and Vedolizumab in Patients with Ulcerative Colitis Resistant to Initial Treatment

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Tofacitinib
    • Infliximab
    • Vedolizumab
    Poland

  • Study of Azacitidine Treatment in Patients with VEXAS Syndrome

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • VEXAS syndrome
    Investigated Drugs:
    • Azacitidine
    Denmark Finland Norway Sweden

  • Study on Buprenorphine for Treating Severe Suicidal Thoughts in Patients with Major Depression

    Recruiting

    2 1 1
    Investigated Drugs:
    • Buprenorphine
    France

  • Study on the Effectiveness of 2LPAPI with Interferon Alfa in Clearing Genital HPV Infections in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Papilloma viral infection
    Investigated Drugs:
    • Ciclosporin A
    • Interferon Alfa
    • Interleukin-1
    Belgium Romania

  • Study on the Effects of Tezepelumab on Airway Inflammation in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    • Placebo
    Denmark

  • Study on Esmolol Hydrochloride, Dobutamine, and Milrinone for Patients with Cardiogenic Shock on V-A ECMO Support

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Esmolol Hydrochloride
    • Milrinone
    • Dobutamine
    The Netherlands
Previous Page
1 … 480 481 482 483 484 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!